Kim-1 regulation of autophagy and MHC presentation in kidney injury
Kim-1 regulation of autophagy and MHC presentation in kidney injury
批准号:
7913584
负责人:
Craig Robert Brooks
金额:
$4.76万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2013-06-30
关键词:
Acute Renal Failure with Renal Papillary NecrosisAutophagocytosisAutophagosomeCell Culture TechniquesCell modelCellsCytoplasmic TailDiagnosisExposure toGoalsIn VitroIncidenceInflammationInjuryKidneyKidney DiseasesKidney FailureLeadMHC Class II GenesMHC antigenMediatingMethodsMorbidity - disease rateMusPatientsPeptidesPhagocytosisPhagosomesProteinsRegulationResearchRoleSolutionsT-LymphocyteTechniquesTherapeutic InterventionWorkantigen processingchemical geneticsin vivoinjuredmortalitymutantpublic health relevancetrafficking
中文摘要
描述(由申请人提供):拟议工作的总体目标是更好地了解Kim-1介导的吞噬作用在肾损伤中的作用。长期目标是确定由Kim-1介导的潜在调节机制,可作为改善肾损伤的靶点。具体来说,我们将使用体外和体内技术来描述Kim-1调节自噬的机制以及Kim-1介导的自噬对MHC II类呈现的影响。在我们的第一个具体目标中,目标是确定Kim-1上调自噬的机制,并将被吞噬的物质靶向自噬体。使用化学和遗传方法,我们将检查金-1阳性吞噬体到自噬体的运输。我们还将确定Kim-1的细胞质尾部是否将被吞噬的碎片靶向自噬体。最后,我们将研究Kim-1细胞质尾部是否将吞噬体靶向自噬体。在第二个特定目标中,我们将研究Kim-1诱导的自噬是否会导致吞噬碎片中的MHC II类肽的呈现。我们将使用两种模型来解决这个问题:不表达Kim-1的细胞,表达Kim-1或表达吞噬缺失突变体的细胞,以及表达吞噬缺失Kim-1的wt小鼠或小鼠。首先,我们将在细胞培养和损伤肾脏中,将Kim-1与自噬体和MHC抗原加工室共定位。然后,我们将比较暴露于吞噬靶点后MHC II类上肽的呈现。最后,我们将研究表达Kim-1的小管细胞在吞噬后激活t细胞是否需要自噬。相关性:急性肾损伤仍然是一种与高发病率和死亡率相关的主要肾脏疾病。AKI的发病率在过去十年中稳步上升,预计还会进一步增加。诊断为肾衰竭的患者死亡率通常为30-50%。尽管研究已经带来了许多治疗选择,并提高了生存率,但需要更多的研究来找到解决这个问题的方法。我们的研究旨在更好地了解一种蛋白质(Kim-1)的功能,这种蛋白质被发现与大多数形式的肾衰竭有关。我们将确定Kim-1是否有助于肾损伤中观察到的自噬和MHC表现,并确定治疗干预的潜在靶点。
英文摘要
DESCRIPTION (provided by applicant): The overarching goal of the proposed work is to better understand the role of Kim-1 mediated phagocytosis in kidney injury. The long term goal is to identify potential regulatory mechanisms mediated by Kim-1 which could be used as targets to ameliorate kidney injury. Specifically, we will use in vitro and in vivo techniques to delineate the mechanism by which Kim-1 regulates autophagy and the effect Kim-1 mediated autophagy has on MHC class II presentation. In our first specific aim, the goal is to identify the mechanism by which Kim-1 upregulates autophagy and targets phagocytosed material to the autophagosome. Using chemical and genetic methods we will examine the trafficking of Kim-1 positive phagosomes to the autophagosome. We will also determine whether the cytoplasmic tail of Kim-1 targets phagocytosed debris to the autophagosome. Finally, we will examine whether Kim-1 cytoplasmic tail targets the phagosome to the autophagosome. In the second specific aim, we will examine whether Kim-1 induced autophagy leads to MHC class II presentation of peptides from the phagocytosed debris. We will approach this using two models cells not expressing Kim-1, expressing Kim-1 or expressing a phagocytosis null mutant and wt mice or mice expressing a phagocytosis null Kim- 1. First, we will co-localize Kim-1 with the autophagosome and MHC antigen processing compartment in cell culture and injured kidneys. We will then compare the presentation of peptides on MHC class II, following exposure to phagocytic targets. Finally, we will examine whether autophagy is necessary for Kim-1 expressing tubule cells to activate T-cells following phagocytosis. Relevance: Acute kidney injury remains a major kidney disease associated with high morbidity and mortality. The incidence of AKI has been steadily increasing over the past decade and is expected to increase further. The mortality rate of patients diagnosed with kidney failure is often 30-50%. Although research has lead to many treatment options and increased survivability, more research is needed to find a solution to this problem. Our study is aimed at better understanding the function of a protein (Kim-1) which is found associated with most forms of kidney failure. We will determine whether Kim-1 contributes to the autophagy and MHC presentation observed in kidney injury as well as identify potential targets for therapeutic intervention.
PUBLIC HEALTH RELEVANCE: Acute kidney injury remains a major kidney disease associated with high morbidity and mortality. The incidence of AKI has been steadily increasing over the past decade and is expected to increase further. The mortality rate of patients diagnosed with kidney failure is often 30-50%. Although research has lead to many treatment options and increased survivability, more research is needed to find a solution to this problem. Our study is aimed at better understanding the function of a protein (Kim-1) which is found associated with most forms of kidney failure. We will determine how Kim-1 regulates autophagy and whether this autophagy contributes to the inflammation observed in kidney injury as well as identifies potential targets for therapeutic intervention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of cyclin G1 in chronic kidney disease
-
批准号:10371058
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2019
-
负责人:Craig Robert Brooks
-
依托单位:
The role of cyclin G1 in chronic kidney disease
-
批准号:10597001
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2019
-
负责人:Craig Robert Brooks
-
依托单位:
The role of cyclin G1 in chronic kidney disease
-
批准号:9884760
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2019
-
负责人:Craig Robert Brooks
-
依托单位:
Proximal tubule Kim-1 expression modulates acute and chronic kidney injury
-
批准号:8568088
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2013
-
负责人:Craig Robert Brooks
-
依托单位:
Proximal tubule Kim-1 expression modulates acute and chronic kidney injury
-
批准号:8699766
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2013
-
负责人:Craig Robert Brooks
-
依托单位:
Kim-1 regulation of autophagy and MHC presentation in kidney injury
-
批准号:8290478
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2010
-
负责人:Craig Robert Brooks
-
依托单位:
Kim-1 regulation of autophagy and MHC presentation in kidney injury
-
批准号:8268834
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2010
-
负责人:Craig Robert Brooks
-
依托单位: